{"id":8214,"date":"2021-01-14T12:00:04","date_gmt":"2021-01-14T12:00:04","guid":{"rendered":"https:\/\/www.scmp.com\/news\/china\/science\/article\/3117750\/coronavirus-chinese-media-champion-sinovacs-vaccine-not"},"modified":"2021-01-14T12:00:04","modified_gmt":"2021-01-14T12:00:04","slug":"coronavirus-chinese-media-champion-sinovacs-vaccine-but-not-everybody-is-convinced","status":"publish","type":"post","link":"https:\/\/radiofree.asia\/2021\/01\/14\/coronavirus-chinese-media-champion-sinovacs-vaccine-but-not-everybody-is-convinced\/","title":{"rendered":"Coronavirus: Chinese media champion Sinovac\u2019s vaccine but not everybody is convinced"},"content":{"rendered":"When Brazilian researchers announced lower-than-expected phase 3 results for a Chinese coronavirus vaccine clinical trial, the response was swift.Various regulators around the world said they would take a close look at the data for Sinovac Biotech\u2019s CoronaVac product, which the company\u2019s Brazilian partner, the Butantan Institute, said on Tuesday had a roughly 50 per cent general efficacy rate \u2013 well below the 78 per cent reported earlier.But there was little mention in Chinese media on Thursday\u2026\n